Akums Drugs & Pharmaceuticals Ltd., India’s leading contract manufacturing pharmaceutical company, has proudly announced the attainment of the prestigious Good Manufacturing Practice (GMP) Certificate from ANVISA, the Brazilian Health Regulatory Agency. This achievement marks a significant advancement for Akums in the Brazilian pharmaceutical market, particularly in the field of injectables. ANVISA is renowned globally for its stringent regulatory standards, and the certification reflects Akums’ commitment to upholding the highest levels of quality, safety, and compliance. By meeting Brazilian legislation and World Health Organization (WHO) guidelines on Good Manufacturing Practices, Akums’ facility in Haridwar, Uttarakhand has demonstrated its excellence in producing a diverse range of sterile dosage forms, including penicillin powders, large and small volume parenteral solutions. Equipped with cutting-edge technologies and adhering to strict regulatory protocols, the facility ensures that every product meets stringent safety, precision, and therapeutic efficacy standards. This certification is a testament to Akums’ dedication to expanding into regulated markets and providing top-notch manufacturing solutions to global pharmaceutical firms. With this milestone, Akums is poised to assist its international partners in ramping up production in Brazil and other Latin American nations, facilitating timely access to high-quality medications. Akums Drugs & Pharmaceuticals Ltd. has built a solid reputation as a reliable contract development and manufacturing organization (CDMO), offering over 4,100 commercialized formulations across a wide range of dosage forms and therapeutic categories.
Read more from pharmabiz.com